BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Snipelisky D, Kelly J, Levine JA, Koepp GA, Anstrom KJ, McNulty SE, Zakeri R, Felker GM, Hernandez AF, Braunwald E, Redfield MM. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices. Circ Heart Fail 2017;10:e003878. [PMID: 28588021 DOI: 10.1161/CIRCHEARTFAILURE.117.003878] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Vaz-salvador P, Adão R, Vasconcelos I, Leite-moreira AF, Brás-silva C. Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update. Cardiovasc Drugs Ther. [DOI: 10.1007/s10557-021-07306-8] [Reference Citation Analysis]
2 Kitamura M, Izawa KP, Ishihara K, Yaekura M, Nagashima H, Yoshizawa T, Okamoto N. Predictors of activities of daily living at discharge in elderly patients with heart failure with preserved ejection fraction. Heart Vessels 2021;36:509-17. [PMID: 33123778 DOI: 10.1007/s00380-020-01718-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Borlaug BA, Anstrom KJ, Lewis GD, Shah SJ, Levine JA, Koepp GA, Givertz MM, Felker GM, LeWinter MM, Mann DL, Margulies KB, Smith AL, Tang WHW, Whellan DJ, Chen HH, Davila-Roman VG, McNulty S, Desvigne-Nickens P, Hernandez AF, Braunwald E, Redfield MM; National Heart, Lung, and Blood Institute Heart Failure Clinical Research Network. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial. JAMA 2018;320:1764-73. [PMID: 30398602 DOI: 10.1001/jama.2018.14852] [Cited by in Crossref: 136] [Cited by in F6Publishing: 114] [Article Influence: 34.0] [Reference Citation Analysis]
4 Shiraishi Y, Niimi N, Goda A, Takei M, Kimura T, Kohno T, Kawana M, Fukuda K, Kohsaka S. Assessment of Physical Activity Using Waist-Worn Accelerometers in Hospitalized Heart Failure Patients and Its Relationship with Kansas City Cardiomyopathy Questionnaire. J Clin Med 2021;10:4103. [PMID: 34575215 DOI: 10.3390/jcm10184103] [Reference Citation Analysis]
5 German CA, Brubaker PH, Nelson MB, Fanning J, Ye F, Kitzman DW. Relationships Between Objectively Measured Physical Activity, Exercise Capacity, and Quality of Life in Older Patients With Obese Heart Failure and Preserved Ejection Fraction. J Card Fail 2021;27:635-41. [PMID: 34088379 DOI: 10.1016/j.cardfail.2020.12.025] [Reference Citation Analysis]
6 Niklasson A, Maher J, Patil R, Sillén H, Chen J, Gwaltney C, Rydén A. Living with heart failure: patient experiences and implications for physical activity and daily living. ESC Heart Fail 2022. [PMID: 35081667 DOI: 10.1002/ehf2.13795] [Reference Citation Analysis]
7 Patel RB, Vaduganathan M, Felker GM, Butler J, Redfield MM, Shah SJ. Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial). Am J Cardiol 2019;123:1660-6. [PMID: 30876658 DOI: 10.1016/j.amjcard.2019.02.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
8 Meyer M, LeWinter MM. Heart Rate and Heart Failure With Preserved Ejection Fraction: Time to Slow β-Blocker Use? Circ Heart Fail 2019;12:e006213. [PMID: 31525068 DOI: 10.1161/CIRCHEARTFAILURE.119.006213] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 7.7] [Reference Citation Analysis]
9 Sen-Gupta E, Wright DE, Caccese JW, Wright JA Jr, Jortberg E, Bhatkar V, Ceruolo M, Ghaffari R, Clason DL, Maynard JP, Combs AH. A Pivotal Study to Validate the Performance of a Novel Wearable Sensor and System for Biometric Monitoring in Clinical and Remote Environments. Digit Biomark 2019;3:1-13. [PMID: 32095764 DOI: 10.1159/000493642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
10 Zhang J, Yin Y, Wen Y, Shi F, Wang J. Anxiety and Depression in Patients With Pulmonary Arterial Hypertension in Northwest China: A Cross-Sectional Study. Front Psychiatry 2022;12:758120. [DOI: 10.3389/fpsyt.2021.758120] [Reference Citation Analysis]
11 Greene SJ, Mentz RJ, Fiuzat M, Butler J, Solomon SD, Ambrosy AP, Mehta C, Teerlink JR, Zannad F, O'Connor CM. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure. Circulation 2018;138:1039-53. [PMID: 30354535 DOI: 10.1161/CIRCULATIONAHA.118.034668] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
12 Snipelisky D, Jentzer J, Batal O, Dardari Z, Mathier M. Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension. Clin Cardiol 2018;41:782-7. [PMID: 29604093 DOI: 10.1002/clc.22954] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]